查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529778

标靶蛋白质降解市场市场规模、份额、趋势分析报告：按类型、应用、最终用途、地区、细分市场预测，2024-2030 年

Targeted Protein Degradation Market Size, Share & Trends Analysis Report By Type (PROTAC, LYTACs), By Application (Drug Discovery), By End Use (Hospitals And Clinical Laboratories), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

标靶蛋白质降解市场趋势

2023年全球目标蛋白降解市场规模预估为4.528亿美元，预估2024年至2030年复合年增长率为20.72%。癌症和神经退化性疾病等慢性疾病的发生率不断增加，加上生活方式的改变和医疗保健支出的增加，正在加速市场的成长。这些疾病的高盛行率创造了对新型治疗方案的强烈需求并推动了市场成长。例如，根据世界卫生组织（WHO）的资料，2022年将诊断出约2,000万新发癌症病例，并将发生970万癌症相关死亡。此外，据估计，诊断后五年内将有 5,350 万人患有癌症。

该领域研发活动的扩大代表着市场成长的巨大机会。例如，2023年12月，奥地利科学基金（FWF）核准了标靶蛋白质降解特别研究计画（SFB），第二个津贴期又为四年。标靶蛋白质降解特别研究计划 (SFB) 是一项研究倡议，重点是了解和开发针对特定蛋白质进行细胞降解的方法。该计划旨在推进靶向蛋白质降解领域的发展，近年来，该领域因其在药物发现和治疗性介入的潜在应用而引起了广泛关注。

支持性的法规环境，特别是 FDA 和 EMA 等机构简化的核准流程，在加速 TPD 特异性治疗方法的采用方面发挥关键作用。 TPD 市场是由基础技术的快速进步所推动的。蛋白水解靶向嵌合体(PROTAC)、分子黏剂和溶酶体靶向嵌合体(LYTAC) 等创新方法的发展扩大了 TPD 选择性去除致病蛋白的能力。这些技术突破为靶向以前无法治疗的蛋白质开闢了新途径，并推动了 TPD 市场的成长。

人们越来越认识到标靶蛋白水解在解决以前无法治疗的标靶方面的治疗潜力，这是标靶蛋白水解市场的主要驱动力。传统方法常常难以处理难以修饰的蛋白质，但 PROTAC（蛋白水解靶向嵌合体）等技术透过加速致病蛋白质的降解提供了有利的解决方案。这种方法在治疗癌症和神经退化性疾病等疾病方面显示出巨大潜力，而该领域的研究和投资正在迅速增加。美国国立卫生研究院已将 PROTAC 确定为近期药物开发的关键技术。随着临床前研究和早期临床试验的不断成功，製药和生物技术公司正在认识到改变治疗策略的潜力，并寻求将标靶蛋白质降解纳入他们的产品线。

标靶蛋白质降解的全球市场细分报告

该报告预测了全球、区域和国家层面的收益成长，并对 2018 年至 2030 年各子区隔的最新行业趋势进行了分析。在这项研究中，Grand View Research, Inc. 根据类型、应用、最终用途和区域对全球标靶蛋白质降解市场报告进行了细分。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章 标靶蛋白质降解市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
  • 标靶蛋白质降解市场分析工具

第 4 章 标靶蛋白质降解市场：按类型估计和趋势分析

  • 细分仪表板
  • 全球标靶蛋白降解市场类型变异分析
  • 2018-2030 年全球标靶蛋白质降解市场规模及趋势分析（按类型）
  • PROTAC
  • 分子黏剂
  • LYTAC
  • 其他的

第五章 目标蛋白质降解市场：按应用、估计和趋势分析

  • 细分仪表板
  • 全球目标蛋白降解市场应用变化分析
  • 2018-2030 年全球标靶蛋白质降解市场规模及趋势分析（按应用）
  • 药物发现
  • 治疗方法开发

第六章 标靶蛋白质降解市场：最终用途的估计与趋势分析

  • 细分仪表板
  • 全球目标蛋白降解市场的最终用途变化分析
  • 2018-2030 年全球目标蛋白质降解市场规模与趋势分析（依最终用途）
  • 製药和生物技术公司
  • 学术研究所
  • 医院和临床实验室

第七章 标靶蛋白质降解市场：区域估计与趋势分析

  • 2023 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 2018-2030年北美市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年欧洲市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 2018-2030 年亚太市场估计与预测
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市场估计与预测
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018-2030年中东和非洲市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 公司/竞争对手分类
  • 策略规划
  • 2023 年企业市场分析
  • 公司简介/上市公司
    • Bayer AG
    • Bio-Techne
    • BOC Sciences
    • BPS Bioscience, Inc.
    • BroadPharm
    • LifeSensors Inc.
    • MedChemExpress.
    • Merck KGaA
    • Promega Corporation
    • Thermo Fisher Scientific, Inc.
Product Code: GVR-4-68040-351-3

Targeted Protein Degradation Market Trends

The global targeted protein degradation market size was estimated at USD 452.8 million in 2023 and is expected to expand at a CAGR of 20.72% from 2024 to 2030. The constantly growing frequency of chronic disease conditions such as cancer and neurodegenerative diseases, along with changing lifestyles and increasing healthcare spending, are accelerating the market growth. The high prevalence of these diseases creates a strong demand for novel treatment options, driving market growth. For Instance, data from the World Health Organization (WHO) indicates that in 2022, around 20 million individuals were newly diagnosed with cancer, and there were 9.7 million cancer-related deaths. It's estimated that 53.5 million people were living with cancer within five years after receiving their diagnosis.

The expanding number of research and development activities in this field provides significant opportunities for the market to grow. For instance, in December 2023, the Austrian Science Fund (FWF) approved the Special Research Program (SFB) in Targeted Protein Degradation for a second funding period of another four years. The SFB in Targeted protein degradation is a research initiative focusing on understanding and developing methods to target specific proteins for cell degradation. This program aims to advance the field of targeted protein degradation, which has gained significant attention in recent years due to its potential applications in drug discovery and therapeutic interventions.

The supportive regulatory environment, particularly the streamlined approval processes by agencies such as the FDA and EMA, has played a crucial role in accelerating the adoption of TPD-based therapies. The TPD market is driven by rapid advancements in the underlying technologies. The development of innovative approaches, such as proteolysis-targeting chimeras (PROTACs), molecular glues, and lysosome-targeting chimaeras (LYTACs), has expanded TPD's capabilities to selectively eliminate disease-causing proteins. These technological breakthroughs have opened up new avenues for targeting previously undruggable proteins, driving the growth of the TPD market.

The increasing recognition of the therapeutic potential of targeted protein degradation in addressing previously undruggable targets is a key driver for the targeted protein degradation market. Traditional approaches often struggle with proteins that are difficult to modulate, but technologies such as PROTACs (proteolysis-targeting chimeras) provide a favorable solution by promoting the degradation of disease-causing proteins. This method has shown considerable promise in treating conditions such as cancer and neurodegenerative disorders, sparking a surge in research and investment in this area. The National Institute of Health highlights PROTACs as a leading drug development technology in recent years. The increasing success in preclinical and early-phase clinical trials drives pharmaceutical and biotech companies to integrate targeted protein degradation into their pipelines, recognizing its potential to transform therapeutic strategies.

Global Targeted Protein Degradation Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global targeted protein degradation market report based on type, application, end use, and region.

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • PROTAC
  • Molecular Glues
  • LYTACs
  • Others
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Drug Discovery
  • Therapy Development

Cancer

Neurology

Infectious Diseases

Cardiovascular Diseases

Others

  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals & Clinical Laboratories
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

China

Japan

India

South Korea

Australia

Thailand

  • Latin America

Brazil

Argentina

  • MEA

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Application Segment
    • 1.2.3. End-Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Targeted Protein Degradation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing frequency of chronic diseases
      • 3.2.1.2. Research and development activities
      • 3.2.1.3. Increasing recognition of the therapeutic potential of targeted protein degradation
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost
      • 3.2.2.2. Stringent regulations associated with approvals for novel TPD based therapies
  • 3.3. Targeted Protein Degradation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Targeted Protein Degradation Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Targeted Protein Degradation Market Type Movement Analysis
  • 4.3. Global Targeted Protein Degradation Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. PROTAC
    • 4.4.1. PROTAC market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Molecular Glues
    • 4.5.1. Molecular Glues market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. LYTACs
    • 4.6.1. LYTACs market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Targeted Protein Degradation Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Targeted Protein Degradation Market Application Movement Analysis
  • 5.3. Global Targeted Protein Degradation Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Drug Discovery
    • 5.4.1. Drug Discovery market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Therapy Development
    • 5.5.1. Therapy Development market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Cancer
      • 5.5.2.1. Cancer market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. Neurology
      • 5.5.3.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Infectious Diseases
      • 5.5.4.1. Infectious Diseases market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. Cardiovascular Diseases
      • 5.5.5.1. Cardiovascular Diseases market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Others
      • 5.5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Targeted Protein Degradation Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Targeted Protein Degradation Market End-Use Movement Analysis
  • 6.3. Global Targeted Protein Degradation Market Size & Trend Analysis, by End-Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & Research Institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Hospitals & Clinical Laboratories
    • 6.6.1. Hospitals & Clinical Laboratories market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Targeted Protein Degradation Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory framework
      • 7.4.2.4. Target disease prevalence
      • 7.4.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory framework
      • 7.4.3.4. Target disease prevalence
      • 7.4.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory framework
      • 7.4.4.4. Target disease prevalence
      • 7.4.4.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Target disease prevalence
      • 7.5.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Target disease prevalence
      • 7.5.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory framework
      • 7.5.4.4. Target disease prevalence
      • 7.5.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory framework
      • 7.5.5.4. Target disease prevalence
      • 7.5.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory framework
      • 7.5.6.4. Target disease prevalence
      • 7.5.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Regulatory framework
      • 7.5.7.4. Target disease prevalence
      • 7.5.7.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Regulatory framework
      • 7.5.8.4. Target disease prevalence
      • 7.5.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.9. Denmark
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Competitive scenario
      • 7.5.9.3. Regulatory framework
      • 7.5.9.4. Target disease prevalence
      • 7.5.9.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Target disease prevalence
      • 7.6.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Target disease prevalence
      • 7.6.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Target disease prevalence
      • 7.6.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Target disease prevalence
      • 7.6.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. Target disease prevalence
      • 7.6.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Target disease prevalence
      • 7.6.7.4. Regulatory framework
      • 7.6.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Target disease prevalence
      • 7.7.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Target disease prevalence
      • 7.7.3.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Target disease prevalence
      • 7.8.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory framework
      • 7.8.3.4. Target disease prevalence
      • 7.8.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Regulatory framework
      • 7.8.4.4. Target disease prevalence
      • 7.8.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Regulatory framework
      • 7.8.5.4. Target disease prevalence
      • 7.8.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Bayer AG
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Type benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Bio-Techne
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Type benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. BOC Sciences
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Type benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. BPS Bioscience, Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Type benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. BroadPharm
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Type benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. LifeSensors Inc.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Type benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. MedChemExpress.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Type benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Merck KGaA
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Type benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Promega Corporation
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Type benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Thermo Fisher Scientific, Inc.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Type benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global Targeted protein degradation market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 6 North America Targeted protein degradation market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 13 Canada Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 16 Mexico Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 17 Mexico Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 19 Europe Targeted protein degradation market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 23 Germany Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 26 UK Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 27 UK Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 29 France Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 30 France Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 31 France Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 32 Italy Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 35 Spain Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 38 Denmark Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 39 Denmark Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 41 Sweden Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 42 Sweden Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 44 Norway Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 45 Norway Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Targeted protein degradation market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 51 China Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 52 China Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 53 China Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 54 Japan Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 55 Japan Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 57 India Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 58 India Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 59 India Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 60 South Korea Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Korea Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 63 Australia Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 64 Australia Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 66 Thailand Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 67 Thailand Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 69 Latin America Targeted protein degradation market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 71 Latin America Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 73 Brazil Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 74 Brazil Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 76 Argentina Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 79 MEA Targeted protein degradation market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 81 MEA Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 82 MEA Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 83 South Africa Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 84 South Africa Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 89 UAE Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 90 UAE Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Targeted Protein Degradation market: Market outlook
  • Fig. 5 Targeted Protein Degradation market: Segment outlook
  • Fig. 6 Targeted Protein Degradation market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Targeted Protein Degradation market driver impact
  • Fig. 9 Targeted Protein Degradation market restraint impact
  • Fig. 10 Targeted Protein Degradation market: Type outlook and key takeaways
  • Fig. 11 Targeted Protein Degradation market: Type movement analysis
  • Fig. 12 PROTAC market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Molecular Glues market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 LYTACs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Targeted Protein Degradation market: Application outlook and key takeaways
  • Fig. 17 Targeted Protein Degradation market: Application movement analysis
  • Fig. 18 Drug Discovery market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Therapy Development market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Infectious Diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Cardiovascular Diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Targeted Protein Degradation market: End-Use outlook and key takeaways
  • Fig. 26 Targeted Protein Degradation market: End-Use movement analysis
  • Fig. 27 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 28 Academic & Research Institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Hospitals & Clinical Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Global Targeted Protein Degradation market: Regional outlook and key takeaways
  • Fig. 32 Global Targeted Protein Degradation market: Regional movement analysis
  • Fig. 33 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Target Disease Prevalence
  • Fig. 37 Key country dynamics
  • Fig. 38 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Target Disease Prevalence
  • Fig. 40 Key country dynamics
  • Fig. 41 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Target Disease Prevalence
  • Fig. 43 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Target Disease Prevalence
  • Fig. 47 Key country dynamics
  • Fig. 48 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Target Disease Prevalence
  • Fig. 50 Key country dynamics
  • Fig. 51 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Target Disease Prevalence
  • Fig. 53 Key country dynamics
  • Fig. 54 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Target Disease Prevalence
  • Fig. 56 Key country dynamics
  • Fig. 57 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Target Disease Prevalence
  • Fig. 59 Key country dynamics
  • Fig. 60 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Target Disease Prevalence
  • Fig. 62 Key country dynamics
  • Fig. 63 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Target Disease Prevalence
  • Fig. 65 Key country dynamics
  • Fig. 66 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Target Disease Prevalence
  • Fig. 68 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Target Disease Prevalence
  • Fig. 72 Key country dynamics
  • Fig. 73 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Target Disease Prevalence
  • Fig. 75 Key country dynamics
  • Fig. 76 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Target Disease Prevalence
  • Fig. 78 Key country dynamics
  • Fig. 79 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Target Disease Prevalence
  • Fig. 81 Key country dynamics
  • Fig. 82 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Target Disease Prevalence
  • Fig. 84 Key country dynamics
  • Fig. 85 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Target Disease Prevalence
  • Fig. 87 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Target Disease Prevalence
  • Fig. 91 Key country dynamics
  • Fig. 92 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Target Disease Prevalence
  • Fig. 94 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Target Disease Prevalence
  • Fig. 98 Key country dynamics
  • Fig. 99 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Target Disease Prevalence
  • Fig. 101 Key country dynamics
  • Fig. 102 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Target Disease Prevalence
  • Fig. 104 Key country dynamics
  • Fig. 105 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 106 Target Disease Prevalence